Archive — US — techcrunch
Radiology AI software provider Gleamer expands into MRI with two smallacquisitions
Gleamer, a French startup specializing in AI for medical imaging, is expanding into MRI by acquiring Pixyl and Caerus Medical. With CE and FDA certifications for their products, Gleamer aims to enhance diagnostic accuracy in radiology. The company currently serves 2,000 institutions globally and has processed 35 million examinations, positioning itself for a future where preventive imaging becomes standard.
Key points
- Gleamer focuses on AI tools for medical imaging, initially successful with X-rays and mammographies.
- Acquired Pixyl and Caerus Medical to expedite growth in MRI analysis.
- Gleamer's software, certified by CE and FDA, has processed 35 million tests across 45 countries.
- The startup aims to tackle complexities in MRI, including detection and segmentation tasks.
- CEO envisions routine whole body MRIs in the future, emphasizing AI's role in improving diagnostic sensitivity.
Why it matters
- Increase in AI adoption in healthcare since 2015, despite earlier failures of some startups.
- Rise of telemedicine and preventive healthcare initiatives amidst ongoing global health challenges.
- The need for efficient medical imaging tools due to a shortage of radiologists in many regions.
Gleamer's strategic acquisitions and advancements in AI promise to revolutionize MRI diagnostics, potentially reshaping the future of preventive healthcare and addressing systemic challenges in medical imaging.